Insider · CIK 0001677455
Karah Herdman Parschauer
Files at RARE (Ultragenyx Pharmaceutical Inc.), EOLS (Evolus, Inc.), TNYA (Tenaya Therapeutics, Inc.). First filing Mar 14, 2025, latest Sep 12, 2025.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
RARE: Ultragenyx Pharmaceutical Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
EOLS: Evolus, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 31Weak | Ultragenyx Pharmaceutical Inc. | $76k 2,450 shares | -3% | +15% from low-49% from high | |
| 51Moderate | Evolus, Inc. | $167k 12,888 shares | -29% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | EOLS Evolus, Inc. | AGrant or award Common Stock | +45,559 | $0.00 | $0 | 77,742 | Feb 19, 2026 |
| Sep 12, 2025 | RARE Ultragenyx Pharmaceutical Inc. | SOpen-market sale Common Stock | -2,450 | $31.17 | $76k | 73,271 | Sep 12, 2025 |
| May 29, 2025 | TNYA Tenaya Therapeutics, Inc. | AGrant or award Stock Option (Right to buy)derivative | +107,400 | $0.00 | $0 | 107,400 | May 30, 2025 |
| Mar 12, 2025 | EOLS Evolus, Inc. | SOpen-market sale Common Stock | -12,888 | $12.99 | $167k | 32,183 | Mar 14, 2025 |
| Mar 7, 2025 | EOLS Evolus, Inc. | AGrant or award Common Stock | +7,364 | $0.00 | $0 | 45,071 | Mar 11, 2025 |
| Mar 7, 2025 | EOLS Evolus, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +11,146 | $0.00 | $0 | 11,146 | Mar 11, 2025 |
| Oct 18, 2024 | TNYA Tenaya Therapeutics, Inc. | AGrant or award Stock Option (Right to buy)derivative | +34,000 | $0.00 | $0 | 34,000 | Oct 21, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.